Francis (Frank) Knuettel II

Chief Financial Officer, OS Therapies Incorporated

In the seat. First published here October 28, 2026; built from records as of October 28, 2026.

Francis (Frank) Knuettel II has been Chief Financial Officer of OS Therapies Incorporated since September 29, 2026, according to the company's filing of October 5, 2026.¹

The filing gives Francis (Frank) Knuettel II's previous role as Chief Financial Officer at Pelthos Therapeutics Inc.¹ Francis (Frank) Knuettel II joined from outside OS Therapies Incorporated, by the record's reading of the filing.¹ The filing shows an earlier chief financial officer seat, so this is not Francis (Frank) Knuettel II's first.¹

Seats

The seat in the record

Company	Title as filed	Standing	Filings
OS Therapies Incorporated (OSTX) Pharmaceutical Preparations	Chief Financial Officer	In the seat	1

Company names link to the company's page in the record at CFO Tribune, which holds the seat history.

The record

Filing by filing, latest first

September 29, 2026effective
OS Therapies Incorporated appointed Francis (Frank) Knuettel II as Chief Financial Officer, effective September 29, 2026. Profile of Christopher P. Acevedo.
Effective September 29, 2026, the Board of Directors of OS Therapies Incorporated (the “Company”) appointed Francis (Frank) Knuettel II to serve as Chief Financial Officer of the Company and Kerry Clem to serve as Chief Commercial Officer of the Company.
[1] Filing by OS Therapies Incorporated, filed with the SEC on October 5, 2026. Read the filing. The record at CFO Tribune.

Sources

Current report filed with the SEC, OS Therapies Incorporated. U.S. Securities and Exchange Commission, EDGAR, filed October 5, 2026. sec.gov; record.

Corrections and removal

If a line here is wrong, or Francis (Frank) Knuettel II wants this profile taken down, write to corrections@cfospotlights.com. Corrections are made on the page with a dated note; removal requests are answered within 72 hours. The underlying filings stay public at the SEC.